(NASDAQ:NDAQ), NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) has scheduled its first quarter 2025 financial results announcement. Who: Nasdaq's CEO, CFO, and additional members of its senior management team What: Review Nasdaq's first quarter 2025 financial results When: Thursday, April 24, 2025 Results Call: 8:00 AM Eastern Senior management will be […]
(NASDAQ:DFLI),(NASDAQ:DFLIW), Fourth Quarter Revenue Growth of 17% Led by Significant OEM GrowthDebt Restructuring and Concurrent Capital Raise Enhance Financial Position and LiquidityInitiates Corporate Optimization ProgramGuides to First Quarter 2025 Net Sales of Approximately $13.3 MillionTargets Positive Adjusted EBITDA in Fourth Quarter 2025 RENO, Nev., March 24, 2025 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (“Dragonfly
(NasdaqGM:KIDS), WARSAW, Ind., March 24, 2025 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it was selected as one of the 2025 Best Places to Work in Indiana. This is the 9th time the Company has been recognized by
(NASDAQ:OCX), Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 million GraftAssure RUO assay launched July 2024 Signed strategic partner and investor, Bio-Rad Laboratories Fully funded clinical kitted product development with $50+ million in equity raises Advanced science in transplant; achieved Medicare claims expansion IRVINE, Calif., March 24, 2025 (GLOBE
(NYSE MKT:AEON),(NYSE MKT:AEON.WS),(NYSE MKT:AEON-WS), – Initiated analytical studies in Q4 2024 to prepare for a potential Biosimilar Biological Product Development (“BPD”) Type 2a meeting with the FDA in the second half of 2025 – – Pursuing a 351(k) regulatory pathway for ABP-450, which offers potential access to the U.S. market under a single approval for
(NASDAQ:XAIR), First-in-human studies anticipated to begin in 2026 Engaged a top tier U.S. based contract manufacturer to ensure the highest standards of quality Currently in the advanced stages of formulation development for subcutaneous injection, with plans for an oral formulation BOSTON, March 24, 2025 (GLOBE NEWSWIRE) — NeuroNOS, a pioneering biopharmaceutical company focused on developing
(NasdaqGM:ARTV), Initial data for AlloNK(R) from autoimmune program expected H1 2025 Updated clinical data from Phase 1/2 trial exploring AlloNK + rituximab in NHL showing continued durability of response to be presented at a medical conference in 2025 Strengthened key leadership with cell therapy and autoimmune expertise across organization Robust balance sheet with cash, cash
(NASDAQ:OPCH), BANNOCKBURN, Ill., March 24, 2025 (GLOBE NEWSWIRE) — Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2025 on Tuesday, April 29, 2025 before the market opens.
https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Civitas Resources, Inc. (NYSE: CIVI) resulting from allegations that Civitas Resources may have issued materially misleading business information to the investing public. So What: If you purchased Civitas Resources securities you may be
The following issues have been halted by CIRO Company: Silver Tiger Metals Inc. TSX-Venture Symbol: SLVR All Issues: Yes Reason: Pending News Halt Time (ET): 3:53 PM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair